Clinical trial Recruiting at 1 site Interventional Ages 19 to 45 Women only

Comparing a hemostatic agent to sutures for ovarian cyst surgery

Official title: A Multi-center, Randomized, Investigator-initiated Trial to Evaluate the Efficacy of PRreservation of ovArian Function, Hemostasis, and sAfety of a Hemostatic Agent Versus Suturing During Laparoscopic Ovarian Cystectomy for Endometrioma

Run by Seoul National University Hospital · NCT04643106 · Data updated 2026-11-12

This study tests whether using a special hemostatic agent instead of stitches during ovarian cyst surgery helps women with endometriomas recover better and keep their ovaries healthy.

Quick facts

Study typeInterventional
Ages19 Years to 45 Years
SexWomen only
Enrollment90 (estimated)
SponsorSeoul National University Hospital
Academic / other
Locations2 sites (Goyang-si, Gyeonggi-do and 1 other locations)
StatusRecruiting
StartedFebruary 25, 2021
Main results expectedDecember 31, 2025
Study endsDecember 31, 2026
Registry record updatedJune 26, 2023
Trial IDNCT04643106 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are women aged 19-45 with a diagnosis of unilateral or bilateral ovarian endometriosis planning to undergo laparoscopic ovarian cystectomy.

Probably not a fit

Patients with ovarian malignancy, those under 19 or over 45, or those with hormonal therapy in the last three months may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of a hemostatic agent compared to traditional suturing during laparoscopic ovarian cystectomy in women with endometriomas. It focuses on how these methods impact hemostatic function and the preservation of ovarian function post-surgery. Patients will be assessed for ovarian function through hormone levels and ovarian volume at various intervals after the procedure. The study aims to determine which technique is safer and more effective in maintaining ovarian health.

Why it matters

Potential benefit: If successful, this study could lead to improved surgical outcomes and better preservation of ovarian function for women undergoing cystectomy.

How similar studies have gone: While this approach is being evaluated, similar studies have shown promise in improving surgical outcomes, though this specific comparison may be novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Informed consent.
* Age: 19-45 year-old women
* American Society of Anesthesiologists Physical Status classification 1 or 2
* Plan of laparoscopic ovarian cystectomy for unilateral or bilateral ovarian endometriosis diagnosed by ultrasonography
* Regular menstruation every 21-45 days

Exclusion Criteria:

* No 'ovarian' endometriosis
* Suspicious disease of ovarian malignancy
* Age: 18 and younger, 46 and older
* Pregnancy or breastfeeding.
* Lower than 0.05 ng/ml of serum Anti-mullerian hormone level
* Hormonal therapy within recent 3 months
* Considered as inappropriate by the researcher's judgment.

Where it's running

  • Seoul National University Hospital
    Seoul, South Korea
    Recruiting
  • Dongguk University Ilsan Hospital
    Goyang-si, Gyeonggi-do, South Korea
    Not yet recruiting

Study contacts

  • Principal investigator: Hee seung Kim, MD/PhD — Seoul National University Hospital
  • Study coordinator: Hyunji Lim, MD
  • Email: hyunji3292@gmail.com
  • Phone: 82-2-2072-2821

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.